Themis Bioscience GmbH
Records under this name other than patents Themis Bioscience GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Themis Bioscience GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,655,961 | Recombinant Measles Virus Expressing Chikungunya Virus Polypeptides and Their Applications now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 11,110,162 | Recombinant Zika Vaccines now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 10,894,079 | Chromatography Based Purification Strategies for Viruses now held by Merck Sharp & Dohme LLC Lapsed on the fee record Ended Jan 19, 2025 · High confidence | Lapsed on the fee record | Ended Jan 19, 2025 | High confidence |
| 17/252,210 | Integrated Manufacturing and Chromatographic System for Virus Production now held by Merck Sharp & Dohme LLC Abandoned Abandoned Apr 9, 2024 | Abandoned | Abandoned Apr 9, 2024 | |
| 17/418,197 | Norovirus Vaccines now held by Merck Sharp & Dohme LLC Abandoned Abandoned Dec 2, 2024 | Abandoned | Abandoned Dec 2, 2024 | |
| 18/021,369 | Co-Stimulatory 4-1BBL Ectodomain Polypeptides for Immunomodulation now held by Merck Sharp & Dohme LLC Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |